Quent Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5K Buy
127
+16
+14% +$1.47K ﹤0.01% 1125
2025
Q4
$9.95K Sell
111
-111
-50% -$10.5K ﹤0.01% 1152
2025
Q3
$21.9K Buy
+222
New +$22K ﹤0.01% 835
2025
Q2
Sell
-170
Closed -$19.2K 1286
2025
Q1
$19.2K Sell
170
-113
-40% -$12.1K ﹤0.01% 770
2024
Q4
$29.8K Sell
283
-127
-31% -$13.6K ﹤0.01% 707
2024
Q3
$44.3K Sell
410
-221
-35% -$24.1K ﹤0.01% 698
2024
Q2
$68.5K Buy
631
+1
+0.2% +$118 0.01% 572
2024
Q1
$83.2K Buy
630
+112
+22% +$14K 0.01% 534
2023
Q4
$63K Buy
518
+92
+22% +$10.3K 0.01% 561
2023
Q3
$47.8K Sell
426
-33
-7% -$4.19K 0.01% 593
2023
Q2
$66.8K Hold
459
0.01% 518
2023
Q1
$59.2K Buy
459
+1
+0.2% +$126 0.01% 548
2022
Q4
$58.4K Sell
458
-39
-8% -$4.53K 0.01% 546
2022
Q3
$52K Hold
497
0.01% 533
2022
Q2
$52K Buy
497
+1
+0.2% +$119 0.01% 506
2022
Q1
$64K Buy
496
+30
+6% +$3.62K 0.01% 536
2021
Q4
$57K Buy
+466
New +$61K 0.01% 517

Other funds holding ZBH

Quent Capital's ZBH Position: Q1 2026 in Review

Quent Capital increased its Zimmer Biomet (ZBH) stake by 14% in Q1 2026, buying an estimated $1.47K and bringing the position to 127 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Quent Capital first reported a position in ZBH in Q4 2021 and has held it in 17 quarters since. The position peaked at $83.2K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Quent Capital held 127 shares of Zimmer Biomet worth $11.5K as of Q1 2026.
  • Quent Capital bought 16 Zimmer Biomet shares in Q1 2026, an estimated $1.47K.
  • Zimmer Biomet made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1125 holding.
  • Quent Capital first reported a position in Zimmer Biomet in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Zimmer Biomet position peaked at $83.2K in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.